{
    "SPADE_UN_19015": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_19015",
            "Peptide Name": "6K-1426 (Synthetic AMPs, Temporin-WY2 analog, Lys-rich, Leu-rich, XXA, UCLL1c)",
            "Source": "Designed based an amphibian derived template",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "KKKKKKFLPKLLSALAKIL",
            "Sequence Length": 19,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anti-MRSA",
                "Hemolytic",
                "Antibiofilm"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 2195.86,
            "PI": 10.85,
            "Hydrophobicity": -0.19,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Liao F, Ye Z, Cheng J, Zhu J, Chen X, Zhou X, Wang T, Jiang Y, Ma C, Zhou M, Chen T, Shaw C, Wang L. 2024",
                    "Reference": "Sci Rep. 2024 Aug 13;14(1):18769. doi: 10.1038/s41598-024-67777-1.PubMed",
                    "Title": "Discovery and engineering of a novel peptide, Temporin-WY2, with enhanced in vitro and in vivo efficacy against multi-drug resistant bacteria"
                }
            ],
            "Frequent Amino Acids": "KLA",
            "Absent Amino Acids": "CDEGHMNOQRTUVWY",
            "Basic Residues": 8,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 10,
            "Polar Residues": 11,
            "Positive Residues": 8,
            "Negative Residues": 0,
            "Net Charge": 8,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (80%) to6K-WY2Leu: 26%; K: 42%; A: 11%.Chemical modification:  C-terminal amidated.Activity: active against Gram+ bacteria S. aureus ATCC CRM 6538 or MRSA BAA 1707 or clinical MRSA B038 V1S1 A (MIC 8-16 uM), E. faecalis NCTC 12697 (MIC 16 uM), Gram- E. coli NCTC 8739 or clinical BAA 2340 (MIC 2 uM), P. aeruginosa ATCC 9027 or PA14 or PAO1 (MIC 2-16 uM), K. pneumoniae ATCC 43816 (MIC 2 uM).Antimicrobial robustness: NaCl-insensitive:E. coli (150 mM), KCl-insensitive:E. coli (4. 5 mM), NH4Cl-insensitive:E. coli (6 uM), CaCl2-sensitive:E. coli (2.5 mM), MgCl2-insensitive:E. coli (1 mM),  ZnCl2-insensitive:E. coli (8 mM), FeCl3-insensitive:E. coli (4 uM). Salt-insensitive:E. coli. NaCl-insensitized:P. aeruginosa PA14 (150 mM), KCl-insensitive:P. aeruginosa PA14  (4. 5 mM), NH4Cl-insensitive:P. aeruginosa PA14  (6 uM), CaCl2-insensitive:P. aeruginosai PA14  (2.5 mM), MgCl2-insensitive:P. aeruginosa PA14 (1 mM),  ZnCl2-insensitive:P. aeruginosa PA14 (8 mM), FeCl3-insensitive:P. aeruginosa PA14 (4 uM). Salt-insensitive:P. aeruginosa PA14. However, it is sensitive to PAO1: NaCl-sensitized:P. aeruginosa PAO1 (150 mM), KCl-sensitive:P. aeruginosa PAO1  (4. 5 mM), NH4Cl-sensitive:P. aeruginosa PAO1  (6 uM), CaCl2-sensitive:P. aeruginosai PAO1  (2.5 mM), MgCl2-sensitive:P. aeruginosa PAO1 (1 mM),  ZnCl2-sensitive:P. aeruginosa PAO1 (8 mM), FeCl3-sensitive:P. aeruginosa PAO1 (4 uM). Salt-sensitive:P. aeruginosa PAO1.  Human serum-insensitive:MRSA (%?).Biofilms: S. aureus: Inhibited formation (MBIC 4-8 uM). Disrupt preformed biofilms: E. coli (MBEC 32 uM).Structure:  random coils in NH4AC buffer and helical in 50% TFE.In vitro toxicity: horse RBC: HC50=32 uM.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_08584",
                    "Similarity": 1.0,
                    "Sequence": "KKKK"
                },
                {
                    "SPADE_ID": "SPADE_N_10106",
                    "Similarity": 1.0,
                    "Sequence": "FKFKKKKKKK"
                },
                {
                    "SPADE_ID": "SPADE_N_10107",
                    "Similarity": 1.0,
                    "Sequence": "GFGKGFGKKKKKK"
                }
            ]
        }
    }
}